Lithium as an adjuvant in the postoperative ablation of remnant tissue in low-risk thyroid carcinoma

Thyroid

Volumn 22, Issue 10, 2012, Pages 1002-1006

  Yamazaki, Claudia Akemi ^a   Padovani, Rosalia P ^a   Biscolla, Rosa Paula Mello ^a   Ikejiri, Elza Setsuko ^a   Marchetti, Renata Rosa ^a   Castiglioni, Mario Luiz V ^a   Matsumura, Luiza Kimiko ^a   MacIel, Rui Monteiro De Barros ^a,b   Furlanetto, Reinaldo Perrone ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Fleury   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DIMENHYDRINATE; LITHIUM; RADIOACTIVE IODINE; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROTROPIN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RISK; CANCER SURGERY; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; FEMALE; FOLLOW UP; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALAISE; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMNANT ABLATION; THYROID CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME; WHOLE BODY SCINTISCANNING;

ADULT; AGED; CARCINOMA; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IODINE RADIOISOTOPES; LITHIUM CARBONATE; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; RADIOPHARMACEUTICALS; THYROID NEOPLASMS; THYROIDECTOMY; THYROXINE; WHOLE BODY IMAGING;

EID: 84866982444     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0372     Document Type: Article

References (24)

1. Hundahl SA, Fleming ID, Fremgen AM, Menck HR 1998 A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 83:2638-2648. (Pubitemid 29019586)
2. Mazaferri E, Kloos R 2001 Current aproaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metabol 86:1447-1463. (Pubitemid 32374886)
3. Sherman SI 2002 Editorial: optimizing the outcomes of adjuvant radioiodine therapy in differentiated thyroid carcinoma. J Clin Endocrinol Metabol 87:4059-5062.
4. McCowen KD, Adler RA, Ghaed N, Verdon T, Hofeldt FD 1976 Low dose radioiodine thyroid ablation in postsurgical patients with thyroid cancer. Am J Med 61:52-58.
5. De Groot L, Reilly M 1982 Comparison of 30 and 50mCi doses of iodine-131 for thyroid ablation. Ann Intern Med 96:51-53. (Pubitemid 12205516)
6. Johansen K, Woodhouse NJY, Odugbesan O 1991 Comparison of 1073 MBq and 3700 MBqiodine-131 in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid cancer. J Nucl Med 32:252-254.
7. Bal CS, Kumar A, Pant GS 2004 Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: a randomized clinical trial in 509 patients. J Clin Endocrinol Metabol 89:1666-1673. (Pubitemid 38507919)
8. Mäenpää HO, Heikkonen J, Vaalavirta L, Tenhunen M, Joensuu H 2008 Low vs. high radioiodine activity to ablate the thyroid after thyroidectomy for cancer: a randomized study. PLoS One 3:e1885.
9. Hackshaw A, Harmer C, Mallick U, Haq M, Frankllyn JA 2006 131I activity for remnant ablation in patients with differentiated thyroid cancer: a systematic review. J Clin En-docrinol Metabol 92:28-38. (Pubitemid 46075005)
10. Burrow GN, Burke WR, Himmelhoch JM, Spencer RP, Hershman JM 1971 Effect of lithium on thyroid function. J Clin Endocrinol Metabol 32:647-652.
11. Spaulding SW, Burrow GN, Bermudez F, Himmelhoch JM 1972 The inhibitory effect of lithium on thyroid hormone release in both euthyroid and thyrotoxic patients. J Clin Endocrinol Metabol 35:905-911.
12. Bogazzi F, Bartalena L, Compomori A, Brogioni S, Raino C, Martino F, Rossi G, Lippi F, Pinchera A, Martino E 2002 Treatment with Lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves disease. J Clin Endocrinol Me-tabol 87:4490-4495. (Pubitemid 35247030)
13. Bogazzi F, Giovannetti C, Fessehatsion R, Tanda ML, Campomori A, Compri E, Rossi G, Ceccarelli C, Vitti P, Pinchera A, Bartalena L, Martino E 2010 Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal. J Clin Endocrinol Metabol 95:201-208.
14. Pòns F, Carrió I, Estorch M, Ginjaume M, Pons J, MilianR 1987 Lithium as an adjuvant of 131I uptake when treating patients with well-differentiated thyroid carcinoma. Clin Nucl Med 12:644-647. (Pubitemid 17150081)
15. 131I therapy of metastatic, well differentiated thyroid carcinoma. J Clin Endocrinol Metabol 84:912-916. (Pubitemid 29138217)
16. Vieira JGH, Kunii IS, Nishida SK, Matsumura LK, Russo EMK, Maciel RMB 1992 Desenvolvimento de um método imunofluorimétrico para a dosagem de tirotrofina humana (TSH) no soro e em sangue total colhido em papel de filtro. Arq Bras Endocrinol Metab 36:7-12.
17. Vieira JGH, Tachibana TT, Fonseca RMG, Nishida SK, Ma-ciel RMB 1996 Desenvolvimento de um método imuno-fluorométrico para a medida de anticorpos séricos contra tiroglobulina. Arq Bras Endocrinol Metab 40:232-237.
18. Mazzaferri E 1997 Thyroid remnant 131-I ablation for papillary and follicular thyroid carcinoma. Thyroid 7:265-271. (Pubitemid 27190594)
19. Hay ID, Hutchinson ME, Gonzalez-Losada T, McIver B, Reinalda ME, Grant CS, Thompson GB, Sebo TJ, Goellner JR 2008 Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery 144:980-987.
20. Maxon HR 3rd, Smith HS 1990 Radioiodine-131I in the diagnosis and treatment of metastatic well differentiated thyroid cancer. Endocrinol Metab Clin North Am 19:685-718. (Pubitemid 20282663)
21. Brière J, Pousset G, Darsy P, Guinet 1974 Intérêt de l'asso-ciation lithium-iode 131 dans le traitement des metastases captantes du cancer tyyroïdien. Annales d'Endocrinologie 35:281-282 (abstract).
22. Gershengorn MC, Izumi M, Robbins J 1976 Use of lithium as an adjunct to radioiodine therapy of thyroid carcinoma. J Clin Endocrinol Metabol 42:105-111.
23. Barbaro D, Grosso M, Boni G, Lapi P, Pasquini C, Orsini P, Turco A, Meucci G, Marzola MC, Berti P, Miccoli P, Mariani G, Rubello D 2010 Recombinant human TSH and ablation of post-surgical thyroid remnants in differentiated thyroid cancer: the effect of pre-treatment with furosemide and furosemide plus lithium. Eur J Nucl Med Mol Imaging 37:242-249.
24. Lazarus JH 1998 The effects of lithium therapy on thyroid and thyrotropin-releasing hormone. Thyroid 8:909-913. (Pubitemid 28514183)